Technical Analysis for VSTM - Verastem, Inc.

Grade Last Price % Change Price Change
D 4.00 1.78% 0.07
VSTM closed up 1.78 percent on Friday, November 22, 2024, on 75 percent of normal volume.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Inside Day Range Contraction 0.00%
Crossed Above 20 DMA Bullish 1.78%
Outside Day Range Expansion 1.78%
Wide Bands Range Expansion 1.78%
Fell Below 20 DMA Bearish 5.54%
1,2,3 Pullback Bullish Bullish Swing Setup 5.54%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 5.54%
NR7 Range Contraction 5.54%
Inside Day Range Contraction 5.54%

   Recent Intraday Alerts

Alert Time
Up 5% 1 day ago
Possible Inside Day 1 day ago
Rose Above 10 DMA 1 day ago
10 DMA Resistance 1 day ago
Up 3% 1 day ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing proprietary small molecule drugs targeting cancer stem cells (CSCs) with companion diagnostics. Its programs target the Focal Adhesion Kinase (FAK) and the PI3K/mTOR signaling pathways. The company's lead FAK inhibitor, VS-6063, is in Phase I/Ib testing in ovarian cancer, as well as developing for the treatment of mesothelioma and breast cancer. It is also developing FAK inhibitor VS-4718 and PI3K/mTOR inhibitor VS-5584 in patients with advanced cancers. The company's product candidates target CSCs that have been implicated in aggressive cancers, metastasis, and chemotherapeutic resistance. Verastem, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Oncology Stem Cell Breast Cancer Ovarian Cancer Treatment Of Breast Cancer Signal Transduction Cancer Research mTOR Companion Diagnostic Metastasis Advanced Cancer Mesothelioma Advanced Cancers Cancer Stem Cell Cancer Stem Cells Mtor Inhibitors

Is VSTM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.22
52 Week Low 2.1
Average Volume 929,488
200-Day Moving Average 6.18
50-Day Moving Average 3.32
20-Day Moving Average 3.90
10-Day Moving Average 4.06
Average True Range 0.33
RSI (14) 56.33
ADX 34.89
+DI 24.92
-DI 13.23
Chandelier Exit (Long, 3 ATRs) 3.80
Chandelier Exit (Short, 3 ATRs) 4.10
Upper Bollinger Bands 4.39
Lower Bollinger Band 3.41
Percent B (%b) 0.6
BandWidth 25.24
MACD Line 0.19
MACD Signal Line 0.23
MACD Histogram -0.0449
Fundamentals Value
Market Cap 101.07 Million
Num Shares 25.3 Million
EPS -3.89
Price-to-Earnings (P/E) Ratio -1.03
Price-to-Sales 51.84
Price-to-Book 4.01
PEG Ratio -1.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.51
Resistance 3 (R3) 4.50 4.32 4.43
Resistance 2 (R2) 4.32 4.19 4.33 4.40
Resistance 1 (R1) 4.16 4.11 4.24 4.17 4.37
Pivot Point 3.98 3.98 4.02 3.99 3.98
Support 1 (S1) 3.82 3.85 3.90 3.83 3.63
Support 2 (S2) 3.64 3.77 3.65 3.60
Support 3 (S3) 3.48 3.64 3.58
Support 4 (S4) 3.49